InvestorsHub Logo
Followers 840
Posts 120462
Boards Moderated 18
Alias Born 09/05/2002

Re: DewDiligence post# 475

Tuesday, 05/15/2018 4:41:08 PM

Tuesday, May 15, 2018 4:41:08 PM

Post# of 6217
VXRT 1Q18 results—cash=$17.5M:

https://www.businesswire.com/news/home/20180515006679/en

Vaxart ended the quarter with cash, cash equivalents and short-term investments of $17.5 million compared to $3.0 million at December 31, 2017. The increase was due to cash received from Aviragen upon consummation of the reverse merger on February 13, 2018, offset by cash used in operations.

No CC.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VXRT News